Israel Englander Rigel Pharmaceuticals Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $1.23 Million - $1.72 Million	1,097,151 Added 141.42%	1,872,988 $2.77 Million
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.56 $2.68 Million - $5.8 Million	-3,719,920 Reduced 82.74%	775,837 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $830,323 - $1.35 Million	-741,360 Reduced 14.16%	4,495,757 $5.8 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $2.56 Million - $4.1 Million	2,048,839 Added 64.26%	5,237,117 $6.91 Million
Q4 2022 Feb 14, 2023	SELL	$0.67 - $11.9 $2.69 Million - $47.8 Million	-4,014,660 Reduced 55.74%	3,188,278 $4.78 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $7.23 Million - $80.2 Million	6,576,296 Added 1049.45%	7,202,938 $8.5 Million
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $1.25 Million - $5.97 Million	-1,872,838 Reduced 74.93%	626,642 $708,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $4.55 Million - $7.06 Million	-2,047,389 Reduced 45.03%	2,499,480 $7.47 Million
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $1.17 Million - $1.77 Million	496,945 Added 12.27%	4,546,869 $12 Million
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $2.03 Million - $2.61 Million	-579,659 Reduced 12.52%	4,049,924 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $2.94 Million - $4.32 Million	950,828 Added 25.85%	4,629,583 $20.1 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $8.88 Million - $13.1 Million	2,650,275 Added 257.69%	3,678,755 $12.6 Million
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $927,399 - $1.48 Million	394,638 Added 62.26%	1,028,480 $3.6 Million
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $123,804 - $287,253	69,553 Added 12.33%	633,842 $1.52 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.05 $10.7 Million - $15.6 Million	-7,599,700 Reduced 93.09%	564,289 $1.03 Million
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $459,014 - $1.08 Million	-361,429 Reduced 4.24%	8,163,989 $12.7 Million
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $1.4 Million - $2.13 Million	877,297 Added 11.47%	8,525,418 $18.2 Million
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $1.46 Million - $2.35 Million	895,684 Added 13.26%	7,648,121 $14.3 Million
Q2 2019 Aug 15, 2019	BUY	$2.02 - $2.61 $13.4 Million - $17.3 Million	6,611,063 Added 4676.29%	6,752,437 $17.6 Million
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $13.8 Million - $17.9 Million	-6,843,934 Reduced 97.98%	141,374 $667,000
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $219,008 - $290,185	109,504 Added 1.59%	6,985,308 $18 Million
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $1.57 Million - $2.54 Million	-755,996 Reduced 9.91%	6,875,804 $15.8 Million
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $11.3 Million - $15.6 Million	4,331,723 Added 131.26%	7,631,800 $24.5 Million
Q2 2018 Aug 14, 2018	SELL	$2.83 - $4.11 $2.01 Million - $2.91 Million	-708,595 Reduced 17.68%	3,300,077 $9.34 Million
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $5.54 Million - $7.11 Million	-1,565,661 Reduced 28.09%	4,008,672 $14.2 Million
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $9.22 Million - $12.3 Million	2,854,414 Added 104.94%	5,574,333 $21.6 Million
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $5.93 Million - $6.99 Million	2,719,919	2,719,919 $6.91 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account